HI SR122

Department of Health directed to establish a Therapeutic Psilocybin Working Group to examine the medicinal and therapeutic effects of psilocybin for treating mental health conditions.

Working group to review federal, state, and local laws regarding therapeutic psilocybin use; medical and scientific research on psilocybin safety and efficacy; and requirements for medical professionals to prescribe psilocybin.

Working group to develop a long-term strategic plan ensuring therapeutic psilocybin or psilocybin-based products are safe, accessible, and affordable for adults 21 years or older.

Membership includes the Director of Health (chairperson), Attorney General, Dean of John A. Burns School of Medicine, legislative committee chairs, Hawaii State Council on Mental Health chairperson, and invited physicians and psychiatrists.

Preliminary report due to Legislature 20 days before 2022 Regular Session; final report with proposed legislation due 20 days before 2023 Regular Session; working group dissolves July 1, 2023.